内镜出口手术与药物治疗BPH对情绪障碍发生的影响
本研究基于TriNetX回顾性队列,经1:1倾向评分匹配后纳入10,048对男性,比较内镜出口手术与α受体阻滞剂单药或联合5α还原酶抑制剂治疗BPH后新发抑郁、焦虑、自杀意念及双相障碍的风险。结果显示手术与1、3、5年抑郁和焦虑风险显著降低相关,自杀意念和双相障碍无差异。
要点
- 内镜出口手术较α受体阻滞剂单药显著降低1、3、5年抑郁和焦虑风险。
- 手术较α受体阻滞剂联合5α还原酶抑制剂亦降低5年抑郁和焦虑风险。
- 两组间自杀意念和双相障碍发生率无显著差异。
核心结论
- 内镜出口手术与药物治疗BPH相比,5年随访内新发抑郁和焦虑风险显著更低。
研究设计与样本
- 基于TriNetX研究网络的回顾性队列研究,采用2组平行1:1倾向评分匹配分析,比较内镜出口手术与α受体阻滞剂单药及联合5α还原酶抑制剂治疗。
- 匹配后纳入10,048对男性,匹配变量包括人口学、合并症和医疗利用情况。
主要发现
- 与α受体阻滞剂单药相比,手术组1年抑郁RR 0.68(95%CI 0.55-0.84)、3年RR 0.76(95%CI 0.66-0.87)、5年RR 0.81(95%CI 0.72-0.92)。
- 与α受体阻滞剂单药相比,手术组1年焦虑RR 0.74(95%CI 0.61-0.90)、3年RR 0.79(95%CI 0.69-0.90)、5年RR 0.79(95%CI 0.71-0.89)。
- 与联合治疗相比,手术组5年抑郁RR 0.70(95%CI 0.62-0.79)、5年焦虑RR 0.77(95%CI 0.69-0.86)。
- 自杀意念或双相障碍在手术与药物治疗间无差异。
- 敏感性分析限定了≥3次坦索罗辛单药处方或≥3次坦索罗辛及非那雄胺处方者,手术对抑郁和焦虑的保护效应在各时间点均进一步增强(所有P<.0001)。
临床怎么用
- 对BPH患者选择内镜出口手术时,可考虑其潜在降低新发抑郁和焦虑风险的获益。
局限性
- 回顾性队列设计可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the incidence of new-onset depression, anxiety, suicidal ideation, and bipolar disorder among men with BPH treated with endoscopic outlet surgery vs medical management. METHODS: Using the TriNetX Research Network, we conducted a retrospective cohort study with 2 parallel 1:1 propensity score-matched (PSM) analyses comparing endoscopic outlet surgery (TURP, GreenLight PVP, laser enucleation of the prostate, or Aquablation) to (1) third-generation alpha-blocker monotherapy and (2) combination alpha-blocker/5α-reductase inhibitor therapy. After exclusion and matching on demographics, comorbidities, and healthcare utilization, 10,048 matched pairs were included. RESULTS: Surgery was associated with significantly lower rates of depression at 1 year (RR 0.68, 95% CI 0.55-0.84), 3 years (RR 0.76, 95% CI 0.66-0.87), and 5 years (RR 0.81, 95% CI 0.72-0.92) compared to alpha-blocker monotherapy; anxiety was similarly reduced at 1 year (RR 0.74, 95% CI 0.61-0.90), 3 years (RR 0.79, 95% CI 0.69-0.90), and 5 years (RR 0.79, 95% CI 0.71-0.89). Compared to combination therapy, surgery demonstrated greater protective effects for depression (5-year RR 0.70, 95% CI 0.62-0.79) and anxiety (5-year RR 0.77, 95% CI 0.69-0.86). No differences were observed for suicidal ideation or bipolar disorder. In sensitivity analyses restricted to those with ≥3 prescriptions of tamsulosin monotherapy or ≥3 prescriptions each of tamsulosin and finasteride, the protective effects of surgery were further strengthened for both depression and anxiety across all time points (all P <.0001). CONCLUSION: Endoscopic outlet surgery is associated with significantly lower risk of incident depression and anxiety compared to both medical management strategies over 5 years of follow-up.
引用
- Bhambhvani HP, Tzeng M, Lee RK, et al. Endoscopic Outlet Surgery vs Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders. Urology. 2026. PMID: 42456781. doi:10.1016/j.urology.2026.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。